Optiscan Imaging Limited has released a press release.
Optiscan Launches InSpecta Device for Veterinary Medicine
Earlier from Optiscan Imaging
- Halfway Mark Reached in Optiscan Breast Cancer Study
- Second Anniversary of Optiscan and Mayo Clinic Agreement
- Optiscan Receives $1.69m R&D Tax Refund
- Optiscan Submits InSpecta FDA Dossier